Enanta Pharma (ENTA) Misses Q3 EPS by 6c

Enanta Pharma (NASDAQ: ENTA) reported Q3 EPS of $0.13, $0.06 worse than the analyst estimate of $0.19.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• Abivax reports Phase 3 maintenance trial results for obefazimod